Cameron Turtle
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $11.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 600551,940 held (−0%) | $89.14 | $53K | -3.9% |
| Oct 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 2,683549,257 held (−0%) | $90.10 | $242K | -4.9% |
| Oct 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 2,638546,619 held (−0%) | $91.49 | $241K | -6.3% |
| Oct 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 3,989542,630 held (−1%) | $92.31 | $368K | -7.2% |
| Oct 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 4,990537,640 held (−1%) | $93.37 | $466K | -8.2% |
| Oct 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 100537,540 held (−0%) | $93.91 | $9K | -8.8% |
| Sep 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 2,500565,040 held (−0%) | $86.36 | $216K | -0.8% |
| Sep 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 8,400556,640 held (−1%) | $87.15 | $732K | -1.7% |
| Sep 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 3,700552,940 held (−1%) | $88.06 | $326K | -2.7% |
| Sep 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 400552,540 held (−0%) | $89.07 | $36K | -3.8% |
| Aug 5SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 800581,740 held (−0%) | $93.97 | $75K | -8.8% |
| Aug 5SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 7,157574,583 held (−1%) | $95.10 | $681K | -9.9% |
| Aug 5SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 5,635568,948 held (−1%) | $95.93 | $541K | -10.7% |
| Aug 5SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 1,392567,556 held (−0%) | $96.82 | $135K | -11.5% |
| Aug 5SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 16567,540 held (−0%) | $97.46 | $2K | -12.1% |
| Jul 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 10,176587,364 held (−2%) | $87.44 | $890K | -2.0% |
| Jul 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 4,234583,130 held (−1%) | $88.12 | $373K | -2.8% |
| Jul 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 590582,540 held (−0%) | $88.91 | $52K | -3.6% |
| Jun 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 3,557608,983 held (−1%) | $69.40 | $247K | +23.5% |
| Jun 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 8,149600,834 held (−1%) | $70.50 | $575K | +21.5% |
| Jun 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 3,294597,540 held (−1%) | $71.38 | $235K | +20.0% |
| May 1SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 5,300622,240 held (−1%) | $69.54 | $369K | +23.2% |
| May 1SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 3,600618,640 held (−1%) | $70.77 | $255K | +21.1% |
| May 1SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 1,000617,640 held (−0%) | $71.76 | $72K | +19.4% |
| May 1SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 3,100614,540 held (−1%) | $73.14 | $227K | +17.2% |
| May 1SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 1,700612,840 held (−0%) | $74.23 | $126K | +15.4% |
| May 1SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 300612,540 held (−0%) | $74.96 | $22K | +14.3% |
| Apr 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 12,344630,196 held (−2%) | $49.20 | $607K | +74.2% |
| Apr 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 2,656627,540 held (−0%) | $49.92 | $133K | +71.7% |
| Mar 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 5,900651,640 held (−1%) | $41.73 | $246K | +105.3% |
| Mar 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 9,100642,540 held (−1%) | $42.49 | $387K | +101.7% |
| Feb 4SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 957671,583 held (−0%) | $31.82 | $30K | +169.3% |
| Feb 4SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 14,043657,540 held (−2%) | $32.87 | $462K | +160.7% |
| Jan 6SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 12,709674,198 held (−2%) | $30.47 | $387K | +181.2% |
| Jan 6SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 2,191672,007 held (−0%) | $31.79 | $70K | +169.6% |
| Jan 6SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 100671,907 held (−0%) | $32.39 | $3K | +164.6% |
| Dec 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 10,995690,912 held (−2%) | $28.73 | $316K | +198.3% |
| Dec 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 4,005686,907 held (−1%) | $29.83 | $119K | +187.3% |
| Nov 5SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 28,155718,752 held (−4%) | $23.13 | $651K | +270.5% |
| Nov 5SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 16,845701,907 held (−2%) | $23.66 | $399K | +262.2% |
- Sell
CEO Cameron Turtle sold $53K of SYRE at $89.14 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Cameron Turtle sold $242K of SYRE at $90.10 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Cameron Turtle sold $241K of SYRE at $91.49 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Cameron Turtle sold $368K of SYRE at $92.31 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Cameron Turtle sold $466K of SYRE at $93.37 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Cameron Turtle sold $9K of SYRE at $93.91 — pre-scheduled 10b5-1 plan sale.